Neurologic clinical trial - Samus PU-AD-SD-0202 ALS - PU-AD-SD-0202 ALS

Status:

Start-Up

A randomized, double-blind, placebo-controlled pilot study to evaluate the biological activity, safety, and pharmacokinetics of PU-AD in subjects with Amyotrophic Lateral Sclerosis (ALS)

Drug

PU-AD

Phase

Phase 2

Condition

Amyotrophic Lateral Sclerosis (ALS)

Keywords

ALS | Samus